Autres langues CellaVision AB

Actions

CEVI

SE0000683484

Equipement et technologie médicale avancés

Temps réel estimé Cboe Europe Autres places de cotation 15:56:15 29/07/2026			Varia. 5j.	Varia. 1 janv.
153,20 ^SEK	+6,09%		+6,61%	-3,56%

20/07	Danske Bank relève l'objectif de cours de Cellavision à 187 couronnes (contre 180), maintient sa recommandation à l'achat - BN	FW
20/07	DNB Carnegie relève l'objectif de cours de CellaVision à 180 couronnes (contre 175), maintient sa recommandation à l'achat	FW

Autres langues

17/07	CellaVision AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
17/07	CellaVision : Sales recovery with all-time high in Americas
14/07	CellaVision – Consensus estimates Q2 2026
03/07	Invitation to Presentation of the CellaVision Report for the Second Quarter 2026 on July 17, at 11:00 CEST
08/06	Sweden's CellaVision Appoints New CEO
05/06	The Board of CellaVision AB appoints Steve Ferguson as CEO
05/06	CellaVision AB Announces CEO Changes
28/04	CellaVision AB Announces Board Appointments
28/04	Bulletin from the Annual General Meeting of CellaVision AB (publ)
24/04	Cellavision Q1 sales, EBITDA fall
24/04	Softer quarter due to lower sales in EMEA
24/04	CellaVision AB Reports Earnings Results for the First Quarter Ended March 31, 2026
21/04	CellaVision – Consensus estimates Q1 2026
16/04	The Nomination Committee’s proposals for the 2026 Annual General Meeting of CellaVision AB
16/04	CellaVision AB Announces Louise Armstrong-Denby and Mikael Worning Declines Re-Election
10/04	Invitation to Presentation of the CellaVision Report for the First Quarter 2026 on April 24, at 11:00 CEST
01/04	CellaVision publishes its 2025 Annual and Sustainability Report
25/03	NOTICE OF ANNUAL GENERAL MEETING IN CELLAVISION AB (publ)
11/03	The new CellaVision® Bone Marrow Aspirate Application launches in EMEA
11/03	Cellavision Announces Launch of Cellavision Bone Marrow Aspirate Application in EMEA
05/02	Cellavision proposes dividend of SEK 2.75 per share
05/02	Solid Quarter driven by Strong Performance in Americas
05/02	CellaVision AB Reports Earnings Results for the Full Year Ended December 31, 2025
05/02	CellaVision AB announces Annual dividend, payable on May 06, 2026
02/02	CellaVision – Consensus estimates Q4 2025